News > India's PharmEasy plans $200 mn fundraising

India's PharmEasy plans $200 mn fundraising

Indian drug and medical services startup PharmEasy are in talks with investors to raise $200 million, but at a valuation that could be 15% or even 25% lower than last year's $5.1 billion, two people with direct knowledge of deal talks.

Signalling growing stress in India's startup ecosystem, Pharmeasy backed by big-name investors such as Proses, TPG and Temasek, is in talks to secure the new funds.